Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 303

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 19
Chunk 303
---
uant to Section 14, employees covered by this section are entitled to monthly deposits at a rate of8.33%of their monthly salary,
made on their behalf by the Company. Payments in accordance with Section 14 release the Company from any future severance liabilities
in respect of those employees.

Neither severance
pay liability nor severance pay fund under Section 14 for such employees is recorded on the Company’s consolidated balance
sheets.

Severance pay expense
for the years ended December 31, 2022, 2023 and 2024 amounted to $418, $466and $525, respectively.

  Contingent liabilities:  

The Company accounts
for its contingent liabilities in accordance with ASC 450, “ Contingencies” (“ ASC 450”). A provision is recorded when
it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters,
provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel
and other information and events pertaining to a particular matter.

As of December 31,
2023 and 2024, no provision was recorded.

  Basic and diluted net loss per share:  

Prior to the consummation
of the Merger Agreement, the Company computed net loss per share using the two-class method required for participating securities. The
two-class method requires income available to ordinary shareholders for the period to be allocated between Ordinary shares and participating
securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company considered
its Convertible Preferred shares to be participating securities as the holders of the Convertible Preferred shares would have been entitled
to dividends that would be distributed to the holders of Ordinary shares, on a pro-rata basis, on an as-converted basis. These participating
securities did not contractually require the holders of such shares to participate in the Company’s losses. As such, net loss for
the periods presented was not allocated to the Company’s participating securities.

Following the consummation
of the Merger Agreement, the Company’s basic net loss per share is calculated by dividing net loss attributable to ordinary shareholders
by the weighted-average number of shares of Ordinary shares outstanding for the period, without consideration of potentially dilutive
securities. The diluted net loss per share is calculated by giving effect to all potentially dilutive securities outstanding for the period
using the treasury share method or the if